Stay updated on Pembrolizumab in MM Residual Disease Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in MM Residual Disease Clinical Trial page.

Latest updates to the Pembrolizumab in MM Residual Disease Clinical Trial page
- Check5 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, reflecting a new page version in the site's revision history. The core study details and content remain unchanged.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page adds the disease term 'Multiple myeloma' and a related topics entry for MedlinePlus Genetics. The revision tag is updated from v3.5.2 to v3.5.3.SummaryDifference0.2%

- Check33 days agoChange DetectedUpdated the page’s footer/version indicator to **Revision: v3.5.2** and removed some generic “related topics” link text.SummaryDifference0.2%

- Check40 days agoChange DetectedAdded related topics: Multiple Myeloma and MedlinePlus Genetics to the study page.SummaryDifference0.2%

- Check48 days agoChange DetectedRelated topics and the disease label 'Multiple myeloma' plus the 'MedlinePlus Genetics' link were removed; core study information remains unchanged.SummaryDifference0.2%

- Check62 days agoChange DetectedAdded the topic Multiple myeloma and the related topic MedlinePlus Genetics. Updated the site revision from v3.4.3 to v3.5.0.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab in MM Residual Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MM Residual Disease Clinical Trial page.